OFIX - Orthofix Medical Inc.

Orthofix to Report Third Quarter 2026 Financial Results

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2026 financial results on Monday, November 9, 2026, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing 833-461-5787 in the U.S., and 585-542-9983 in all other locations, and referencing th.

Oct 23, 2026 12:00 PM • businesswire.com

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Orthofix Medical Inc. (NASDAQ: OFIX)

NEW YORK, Oct. 21, 2026 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Orthofix Medical Inc. (NASDAQ: OFIX) concerning possible breaches of fiduciary duties. If you are a current shareholder of OFIX, you can request additional information here: https://zlk.com/cases/orthofix-medical-inc-class-action-lawsuit-ofix-2 or contact Joseph E.

Oct 21, 2026 12:18 PM • prnewswire.com (Hide legal announcements)

Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Oct 13, 2026 11:12 AM • prnewswire.com

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Orthofix Medical Inc. (NASDAQ: OFIX)

NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Orthofix Medical Inc. (NASDAQ: OFIX) concerning possible breaches of fiduciary duties. If you are a current shareholder of OFIX, you can request additional information here: https://zlk.com/cases/orthofix-medical-inc-class-action-lawsuit-ofix-2  or contact Joseph E.

Oct 08, 2026 03:35 PM • prnewswire.com (Hide legal announcements)

Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook

Orthofix Medical NASDAQ: OFIX executives said the company's updated outlook reflects the restoration of bone growth stimulation reimbursement, improving trends in biologics and limb reconstruction, and an expected European inventory order, partly offset by a steeper-than-anticipated decline among smaller U.S. spine distributors.

Aug 15, 2026 06:02 PM • marketbeat.com

Orthofix Medical Q2 Earnings Call Highlights

Orthofix Medical NASDAQ: OFIX reported second-quarter results that management said reflected improving operating trends across several businesses, while continued weakness among smaller U.S. spine distributors remained a headwind. The company reiterated its focus on commercial productivity, disciplined investment and profitable growth rather than pursuing revenue growth at any cost.

Aug 05, 2026 10:05 AM • marketbeat.com

Orthofix Medical Inc. (OFIX) Q2 2026 Earnings Call Transcript

Orthofix Medical Inc. (OFIX) Q2 2026 Earnings Call Transcript

Aug 05, 2026 07:00 AM • seekingalpha.com

Bet on 5 Top-Ranked Stocks With Rising P/E

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

Aug 05, 2026 05:51 AM • zacks.com

Orthofix (OFIX) Q2 Earnings and Revenues Surpass Estimates

Orthofix (OFIX) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to earnings of $0.13 per share a year ago.

Aug 05, 2026 05:16 AM • zacks.com

Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused and consistent operating model. The Company also raised its full-year 2026 guidance for both net sales and adjusted EBITDA. All pro forma measures contained within this release exclude the impact of the discontinued M6™ product lines. Highlights Second quart.

Aug 05, 2026 03:00 AM • businesswire.com

Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 29, 2

Jul 29, 2026 08:00 AM • gurufocus.com

Analysts Estimate Orthofix (OFIX) to Report a Decline in Earnings: What to Look Out for

Orthofix (OFIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Jul 29, 2026 07:02 AM • zacks.com

Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Jul 29, 2026 07:00 AM • prnewswire.com

Wall Street Analysts Think Orthofix (OFIX) Could Surge 33.28%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 33.3% in Orthofix (OFIX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Jul 22, 2026 06:56 AM • zacks.com

MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth

The Johnson & Johnson, Pacira BioSciences and Orthofix executive takes charge of commercial execution as adoption of Canopus by eXeX accelerates across hospital systems in the United States and United Kingdom, and as eXeX launches Canopus Command, the first portal to give hospital leadership a live operational view into step-by-step execution of every surgical case. ORLANDO, Fla.

Jul 21, 2026 05:00 AM • prnewswire.com

Orthofix to Participate in Upcoming Investor Conferences

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Orthofix will participate in the following investor conferences: Needham Virtual MedTech & Diagnostics 1x1 Conference - Virtual, August 10, 2026, 1x1 Meetings Canaccord Genuity's 46th Annual Growth Conference - Boston, August 12, 2026, Fireside Chat Time: 9:30 am Eastern Time Interested parties can access the live and archived webcast of the Canaccord Ge.

Jul 20, 2026 03:00 AM • businesswire.com

Orthofix to Report Second Quarter 2026 Financial Results

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its second quarter 2026 financial results on Wednesday, August 5, 2026, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referenc.

Jul 15, 2026 03:00 AM • businesswire.com

Orthofix (OFIX) Moves 5.1% Higher: Will This Strength Last?

Orthofix (OFIX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Jun 29, 2026 03:51 AM • zacks.com

Orthofix Medical Inc. (OFIX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Orthofix Medical Inc. (OFIX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Jun 08, 2026 07:28 AM • seekingalpha.com

Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, June 5,

Jun 05, 2026 12:00 PM • gurufocus.com

Orthofix price target lowered to $13 from $18 at Canaccord

$13.00 (was $10.28)

Caitlin Roberts · Canaccord Genuity

Aug 10, 2026 07:25 AM • TheFly

Orthofix price target lowered to $14 from $17 at Barrington

$14.00 (was $10.57)

Barrington

Aug 06, 2026 10:04 AM • TheFly

Orthofix price target lowered to $13 from $15 at Stifel

$13.00 (was $10.42)

Thomas Stephan · Stifel Nicolaus

Aug 05, 2026 03:14 PM • TheFly

Orthofix price target raised to $17 from $15 at Barrington

$17.00 (was $9.94)

Barrington

Jul 06, 2026 07:41 AM • TheFly

Orthofix price target lowered to $15 from $17 at Barrington

$15.00 (was $10.41)

Barrington

May 22, 2026 07:34 AM • TheFly

Orthofix price target lowered to $15 from $18 at Stifel

$15.00 (was $10.41)

UBS

May 22, 2026 06:47 AM • TheFly

Orthofix price target lowered to $12 from $14 at TD Cowen

$12.00 (was $10.41)

Cowen & Co.

May 21, 2026 03:43 PM • TheFly

Orthofix Medical (OFIX) PT Lowered to $18 at Canaccord

$18.00 (was $10.41)

Caitlin Burrows · Canaccord Genuity

May 21, 2026 01:22 PM • StreetInsider

Orthofix price target lowered to $18 from $22 at Stifel

$18.00 (was $12.46)

Stifel Nicolaus

Mar 09, 2026 07:12 AM • TheFly

Orthofix price target raised to $18 from $17 at Barrington

$18.00 (was $14.81)

Michael Petusky · Barrington

Nov 05, 2025 09:21 AM • TheFly

Orthofix resumed with a Buy at Stifel

$22.00 (was $16.12)

Stifel Nicolaus

Oct 28, 2025 06:51 AM • TheFly

Stifel Upgrades Orthofix International (OFIX) to Buy

$24.00 (was $18.22)

Mathew Blackman · Stifel Nicolaus

Nov 08, 2024 03:01 AM • StreetInsider

Stifel cuts Orthofix target, says momentum 'faded' during Q2

$31.00 (was $24.11)

Mathew Blackman · Stifel Nicolaus

Jun 28, 2022 09:47 AM • TheFly